This is to inform you that GMP inspection by the Ministry of Health, Armenia had conducted an inspection at the Company s manufacturing facility located at Sikkim, India from 21st November, 2025 to 22nd November, 2025. The said inspection was concluded today with no critical or major observation. Kindly take note of the same.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories' manufacturing facility in Sikkim, India was inspected by the Ministry of Health, Armenia over two days (21st–22nd November 2025) as part of a Good Manufacturing Practice (GMP) audit. The inspection concluded with no critical or major observations, indicating the facility meets required manufacturing quality standards. A clean GMP inspection is important for pharmaceutical companies as it allows them to continue supplying or expand into the Armenian market. The company has asked the stock exchange to take note of the development.
Positive for shareholders — a clean inspection outcome supports continued exports to Armenia and reinforces confidence in the company's manufacturing quality standards, with no near-term regulatory risk from this facility.